(19)
(11) EP 3 307 152 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
13.09.2023 Bulletin 2023/37

(45) Mention of the grant of the patent:
31.05.2023 Bulletin 2023/22

(21) Application number: 16808267.5

(22) Date of filing: 09.06.2016
(51) International Patent Classification (IPC): 
A61N 1/04(2006.01)
A61N 1/36(2006.01)
 A61N 1/39(2006.01)
(52) Cooperative Patent Classification (CPC):
A61N 1/0476; A61N 1/046; A61N 1/36025; A61N 1/3906; A61N 1/3918
(86) International application number:
PCT/US2016/036645
(87) International publication number:
WO 2016/201074 (15.12.2016 Gazette 2016/50)

(54)

MULTIVECTOR PATIENT CONTACT INTERFACE

MULTIVEKTORIELLE PATIENTENKONTAKTSCHNITTSTELLE

INTERFACE MULTI-VECTORIELLE DE CONTACT AVEC LE PATIENT

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 10.06.2015 US 201514736180

(43) Date of publication of application:
18.04.2018 Bulletin 2018/16

(73) Proprietor: Cardio Thrive, Inc.
Concord, CA 94521 (US)

(72) Inventors:
  • SAVAGE, Walter, T.
    Concord, CA 94521 (US)
  • SAVAGE, Shelley, J.
    Concord, CA 94521 (US)
  • RAYMOND, Douglas, M.
    Livermore, CA 94550 (US)
  • GRAY, Peter, D.
    Fairfield, CA 94534 (US)

(74) Representative: Betten & Resch 
Patent- und Rechtsanwälte PartGmbB Maximiliansplatz 14
80333 München
80333 München (DE)


(56) References cited: : 
US-A1- 2001 027 270
US-A1- 2014 317 914
US-A1- 2014 371 567
US-A1- 2014 371 806
 US-A1- 2008 200 973
US-A1- 2014 371 566
US-A1- 2014 371 567
US-B1- 6 714 824
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).